LMCD1 anticorps (AA 105-268) (FITC)

N° du produit ABIN7158338

Détail du produit anti-LMCD1 anticorps (FITC)

Antigène: LMCD1 (LIM and Cysteine-Rich Domains 1 (LMCD1))

Épitope: AA 105-268

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LMCD1 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human LIM and cysteine-rich domains protein 1 protein (105-268AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur LMCD1

Antigène: LMCD1 (LIM and Cysteine-Rich Domains 1 (LMCD1))

Autre désignation: LMCD1 (LMCD1 Produits)

Synonymes: anticorps LMCD1, anticorps AW455500, anticorps AW553074, anticorps dyxin, anticorps LIM and cysteine rich domains 1, anticorps LIM and cysteine-rich domains 1, anticorps LMCD1, anticorps lmcd1, anticorps Lmcd1

Sujet:

Background: Transcriptional cofactor that restricts GATA6 function by inhibiting DNA-binding, resulting in repression of GATA6 transcriptional activation of downstream target genes. Represses GATA6-mediated trans activation of lung- and cardiac tissue-specific promoters. Inhibits DNA-binding by GATA4 and GATA1 to the cTNC promoter (By similarity). Plays a critical role in the development of cardiac hypertrophy via activation of calcineurin/nuclear factor of activated T-cells signaling pathway.

Aliases: Dyxin antibody, LIM and cysteine rich domains 1 antibody, LIM and cysteine rich domains protein 1 antibody, LIM and cysteine-rich domains protein 1 antibody, LMCD1 antibody, LMCD1_HUMAN antibody

UniProt: Q9NZU5